Anna Wald is an Infectious Disease physician. ClinicalTrials.gov lists 7 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Harborview Medical Ctr
600 Broadway, Suite 400
Seattle, WA 981959928
Telephone
206-720-4340Registry record last updated 24 Jan 2012.
Clinical trials
- Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
Sponsor: University of Alabama at Birmingham
- Intradermal, Fractional Dose of HPV Vaccines:
Sponsor: University of Washington
- HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions
Sponsor: Fred Hutchinson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202511 payments
- Bayer Healthcare LLCProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20244 payments$17,704openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
11 NIH research awards on record, funded 1998–2026 per NIH RePORTER. The latest:
- University of Washington Vaccine and Treatment Evaluation Unit
University of Washington
FY2026$1,198,521UM1AI148573 - University of Washington Vaccine and Treatment Evaluation Unit
University of Washington
FY2025$2,527,789UM1AI148573 - University of Washington Vaccine and Treatment Evaluation Unit
University of Washington
FY2024$2,579,381UM1AI148573
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”